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Abstract
Background There is a lack of agreement about applicable instrument to screen frailty in clinical settings.
Aims To analyze the association between frailty and mortality in Finnish community-dwelling older people.
Methods This was a prospective study with 10- and 18-year follow-ups. Frailty was assessed using FRAIL scale (FS) 
(n = 1152), Rockwood’s frailty index (FI) (n = 1126), and PRISMA-7 (n = 1124). To analyze the association between frailty 
and mortality, Cox regression model was used.
Results Prevalence of frailty varied from 2 to 24% based on the index used. In unadjusted models, frailty was associated 
with higher mortality according to FS (hazard ratio 7.96 [95% confidence interval 5.10–12.41] in 10-year follow-up, and 
6.32 [4.17–9.57] in 18-year follow-up) and FI (5.97 [4.13–8.64], and 3.95 [3.16–4.94], respectively) in both follow-ups. Also 
being pre-frail was associated with higher mortality according to both indexes in both follow-ups (FS 2.19 [1.78–2.69], and 
1.69 [1.46–1.96]; FI 1.81[1.25–2.62], and 1.31 [1.07–1.61], respectively). Associations persisted even after adjustments. 
Also according to PRISMA-7, a binary index (robust or frail), frailty was associated with higher mortality in 10- (4.41 
[3.55–5.34]) and 18-year follow-ups (3.78 [3.19–4.49]).
Discussion Frailty was associated with higher mortality risk according to all three frailty screening instrument used. Simple 
and fast frailty indexes, FS and PRISMA-7, seemed to be comparable with a multidimensional time-consuming FI in predict-
ing mortality among community-dwelling Finnish older people.
Conclusions FS and PRISMA-7 are applicable frailty screening instruments in clinical setting among community-dwelling 
Finnish older people.
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Introduction
Frailty is a problematic clinical syndrome [1]. It is defined as 
a loss of resources in several domains leading to the inability 
to respond to physical or psychosocial stress [1–3]. Frailty pre-
dicts increased falls, hospitalization, dependence, morbidity, 
mortality and increase in healthcare costs [1, 2, 4–7]. Preva-
lence of frailty has varied to some extent between studies, but 
it has been found to increase with age and to be higher in 
women than in men [8–13]. Women seem to tolerate frailty 
better than men, as demonstrated by a lower mortality rate 
at any given level of frailty or age among women [11, 14]. 
Anyhow, timely identification of older adults who are frail or 
at risk of frailty constitutes a cornerstone of geriatric medicine 
and quality care for the growing elderly population [2, 15–17].
There is no consensus about the key components and 
assessment of frailty [3, 6, 18]. The ability to predict adverse 
outcomes is the critical point to determine whether an assess-
ment instrument of frailty is effective or not [18]. FRAIL scale 
(FS) is judged to be clinically advantageous due to its simple 
nature and ability to be obtained from data already included 
in a comprehensive geriatric assessment (CGA) [19, 20]. 
Also PRISMA-7 is a fast and easily implemented frailty tool 
in clinical practice [21] and it has been found to have high sen-
sitivity and moderate specificity for identifying frailty among 
community-dwelling older people [21, 22]. Rockwood’s frailty 
index (FI), instead, is more comprehensive or prognostic index 
[23]. FI is well validated and has been applied to multiple 
datasets [17]. Nonetheless, frailty should be recognized in the 
clinical setting. According to the Frailty consensus, all persons 
older than 70 years and all persons with significant weight 
loss (≥ 5%) due to a chronic disease should be screened for 
frailty [24]. Screening for frailty helps clinicians to identify 
and manage the condition early into its progression, facilitate 
clinical decision making and enable to identify those who need 
comprehensive geriatric assessment (CGA), followed by tar-
geted interventions to improve quality of life, prevent adverse 
outcomes, as well as promote an improved allocation of health 
care resources [21, 25–27].
The aim of this study was to analyze whether frailty, defined 
with three different frailty tools, FS, PRISMA-7, and FI, was 
associated with higher mortality risk among Finnish commu-
nity-dwelling older people during 10- and 18-year follow-ups.
Materials and methods
Study design and population
This study is a part of the longitudinal epidemiological 
study carried out in the municipality of Lieto in southwest 
Finland [28]. All persons born in or prior to the year 1933 
(N = 1596) were invited to participate in the baseline exami-
nation which was carried out between March 1998 and Sep-
tember 1999. Of those eligible, 63 died before they were 
examined and 273 refused or did not respond, leaving 1260 
(82%) participants, 533 men and 727 women. Subjects living 
in institutional care (n = 65) or in sheltered housing (n = 18) 
or with missing data of frailty indexes were excluded from 
the analyses.
Frailty
Frailty was characterized using three commonly used 
approaches: FRAIL scale (FS) [19], Rockwood’s frailty 
index (FI) [29, 30], and PRISMA-7 [31, 32]. Data of frailty 
were gathered using an interview and clinical examination 
[28] as well as patient records.
The FS, a 5-item self-reported frailty screening tool, 
includes fatigue, resistance, ambulation, illnesses, and loss 
of weight components. One point was assigned for each 
component. Respondents were classified as robust (0 points), 
pre-frail (1–2 points), or frail (≥ 3 points) according to the 
total score [19]. We used slightly modified version of FS 
(Appendix A). In addition, data of illnesses were gathered 
from patient records instead of self-reporting.
FI consists of at least 30 deficits, such as symptoms, 
signs, disabilities, and laboratory measurements, which are 
readily available in survey or clinical data [4, 33]. In this 
study, FI consisted of 36 items as described in Appendix B. 
For the level of frailty, three groups were identified using 
previously described cut points: robust (FI ≤ 0.08), pre-frail, 
and frail (FI ≥ 0.25) [34].
PRISMA-7 contains seven simple self-reported items 
to identify frailty: age over 85 years, male gender, health 
problems which limit activities, support of another person 
needed, health problems requiring staying at home, social 
support, and use of a walking aid or a wheelchair. One point 
is given for every “yes” responses. Respondents with a 
score of 0–2 are considered to be robust and those with a 
score of 3 or more are considered to be frail [22, 31]. In our 
study, three items of the original PRISMA-7 were replaced 
(Appendix 3).
Mortality
Data from all participants who died before January 2017 
were obtained from the official Finnish Cause of Death Reg-
istry using unique personal identification numbers.
Ethics
The study was conducted according to the guidelines of 
the Declaration of Helsinki. The Ethics Committee of the 
Hospital District of Southwest Finland approved the study 
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protocol. Participants provided written informed consent for 
the study.
Statistical analyses
At baseline, differences between women and men were 
tested using the Chi squared test, Fisher’s exact test or two-
sample t test.
Hazard ratios (HRs) and their 95% confidence intervals 
for all-cause mortality were calculated using Cox propor-
tional hazard models. Proportional hazards assumption was 
tested using Martingale residuals. The follow-up periods 
were calculated from baseline measurements to the end of 
the follow period of 10 and 18 years or to the death of the 
person. Firstly, unadjusted Cox regression analyses were 
conducted for all three frailty indexes. Secondly, Cox regres-
sion analyses for FS and FI indexes were adjusted for age 
and gender which were items of PRISMA-7. The interac-
tion between gender and frailty indexes was included in Cox 
regression models. P values less than 0.05 were considered 
statistically significant. All statistical analyses were per-
formed using SAS System for Windows, version 9.4 (SAS 
Institute Inc., Cary, NC, USA).
Results
Baseline characteristics
The mean age of the participants was 72.7 (SD 6.2, range 
64.0–97.0) years, and 57% were female. More detailed 
baseline characteristics of 1152 participants are shown in 
Table 1. Two percent of the participants were identified 
as frail with FS, 24% with FI, and 17% with PRISMA-7. 
Frailty (both pre-frailty and frailty) was more common 
among women than men according to FS and FI; according 
to PRISMA-7, more men than women were frail. Altogether 
1083 participants had frailty assessed with all three indexes, 
and only one-fifth (20%) was categorized as frail or robust 
identically according to all three indexes (2% frail, 18% 
robust). Table 2 shows overlaps of FS, FI, and PRISMA-7.
Cox models for frailty and mortality
Altogether, 382 (33%) and 776 (67%) subjects deceased 
during the 10- and 18-year follow-ups, respectively. In 
unadjusted Cox regression models, both being frail and 
pre-frail were significantly associated with higher mor-
tality according to FS and FI scales during the 10- and 
18-year follow-ups (Table 3). After adjustments for age 
and gender, these associations remained significant in both 
follow-ups (Table 4). Also according to binary (robust or 
frail) PRISMA-7, frailty predicted higher mortality risk. 
Figure 1 shows age- and gender-adjusted Kaplan–Meier 
survival curves by FS and FI and unadjusted Kaplan–Meier 
survival curves by PRISMA-7. The association of frailty, 
defined by any of the three indexes, and mortality did not 
significantly differ between men and women either in 10- 
or 18-year follow-up.
Table 1  Baseline characteristics of study participants (n = 1152)
a Six years of elementary school
n (%)




 ≥ 85 63 (5)
Female 657 (57)
Living circumstances
 Living with someone 806 (70)
 Living alone 346 (30)
Education
 More than  basica or basic 111 (10)
 Less than basic 1041 (90)
MMSE
 27–30 879 (76)
 < 26 273 (24)
Body mass index, kg/m2








 Current smokers 93 (8)
Frequency of recreational exercising during the previous year
 ≥ 3 times a week 611 (55)
 Once or twice a week 218 (19)
 Less than once a week 290 (26)
Number of prescribed medicines
 < 5 880 (76)
 5–7 200 (17)
 8–9 51 (4)
 ≥ 10 21 (2)





2016 Aging Clinical and Experimental Research (2020) 32:2013–2019
1 3
Discussion
In our study, the prevalence rates of frailty varied from 
2% (according to FS) to 24% (according to FI) based on 
the index used. It is possible that the modified version of 
FS, used in our study, may have underestimated frailty. In 
addition, FS is originally designed to be a short screening 
instrument; FI, instead, is a comprehensive, multidimen-
sional, and more prognostic frailty tool [23].
Both being frail and pre-frail were significantly associ-
ated with higher mortality during 10- and 18-year follow-ups 
both in unadjusted and adjusted models. Also earlier studies 
with follow-up periods from 2 to 12 years have shown that 
frailty assessed using FS [20, 35] or FI [30, 33, 36, 37] was 
a strong predictor of mortality among 65-year-old or older 
community-dwelling population.
The current study also supports results of the earlier 
studies showing that frailty indexes differ substantially in 
how they classified participants as frail [38–41]. However, 
Table 2  Overlaps of FRAIL 
scale, frailty index and 







Robust Pre-frail Frail P value Robust Frail P value
FRAIL scale
 Robust 199 (92) 468 (74) 74 (28) < 0.001 684 (74) 62 (33) < 0.001
 Pre-frail 18 (8) 168 (26) 166 (63) 234 (25) 111 (58)
 Frail 0 (0) 0 (0) 25 (9) 2 (0) 17 (9)
Frailty index (n = 1090)
 Robust 212 (24) 4 (2) < 0.001
 Pre-frail 583 (65) 50 (27)
 Frail 107 (12) 134 (71)
Table 3  Unadjusted hazard 
ratios (HR) and their 95% 
confidence intervals (CI) (in 
parentheses) of FRAIL scale, 
frailty index and PRISMA-7 for 
all-cause mortality during the 
10- and 18-year follow-up
10-year follow-up 18-year follow-up
n (%) HR (95% CI) P value HR (95% CI) P value
FRAIL scale (n = 1152)
 Robust 763 (66) 1 1
 Pre-frail 364 (32) 2.19 (1.78–2.69) < 0.001 1.69 (1.46–1.96) < 0.001
 Frail 25 (2) 7.96 (5.10–12.41) < 0.001 6.32 (4.17–9.57) < 0.001
Frailty index (n = 1126)
 Robust 217 (19) 1 1
 Pre-frail 642 (57) 1.81 (1.25–2.62) 0.002 1.31 (1.07–1.61) 0.011
 Frail 267 (24) 5.97 (4.13–8.64) < 0.001 3.95 (3.16–4.94) < 0.001
PRISMA-7 (n = 1124)
 Robust 928 (83) 1 1
 Frail 196 (17) 4.41 (3.55–5.48) < 0.001 3.78 (3.19–4.49) < 0.001
Table 4  Age- and gender-
adjusted hazard ratios (HR) and 
their 95% confidence intervals 
(CI) (in parentheses) of FRAIL 
scale and frailty index for all-
cause mortality during the 10- 
and 18-year follow-up
10-year follow-up 18-year follow-up
n (%) HR (95% CI) P value HR (95% CI) P value
FRAIL scale (n = 1152)
 Robust 763 (66) 1 1
 Pre-frail 364 (32) 1.69 (1.36–2.10) < 0.001 1.35 (1.15–1.57) < 0.001
 Frail 25 (2) 4.91 (3.10–7.80) < 0.001 3.92 (2.55–6.01) < 0.001
Frailty index (n = 1126)
 Robust 217 (19) 1 1
 Pre-frail 642 (57) 1.75 (1.21–2.54) 0.003 1.27 (1.03–1.56) 0.026
 Frail 267 (24) 4.05 (2.75–5.97) < 0.001 2.85 (2.25–3.63) < 0.001
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frailty can potentially be prevented or treated with physical 
exercise, supplementations, cognitive training and combined 
treatment, vitamin D, and reduction of polypharmacy [24, 
42, 43]. Due to this, the next step is to find out which frail or 
pre-frail persons can benefit from interventions [41].
Frailty (pre-frailty and frailty) was more common among 
women than men according to FS and FI; according to 
PRISMA-7, more men than women were frail. This was 
probably because according to PRISMA-7 one risk point is 
given from male gender. However, the association between 
frailty, defined by any of the three indexes, and mortality did 
not significantly differ between genders. In another Finn-
ish study [14], frailty was strongly associated with higher 
mortality, especially among women. Yet, the association 
between worsening frailty status and mortality risk was more 
prominent among men. In that population-based study, dif-
ferent frailty assessment was used, participants were older 
than in our study, and 10% of the participants were institu-
tionalized [14, 44]. Also according to a meta-analysis, in 
every age group, women had higher FI scores than men but 
lower mortality rate at any given level of frailty or age sug-
gesting that women tolerated frailty better than men [11].
Three different frailty indexes used in this study are 
designed for slightly different purposes; FS and PRISMA-7 
are designed to be screening instruments and FI to be more 
comprehensive or prognostic index which characterizes 
the whole health of an individual [23]. FS is judged to be 
clinically advantageous due to its simple nature and ability 
to be obtained from data already included in a patient CGA 
[19, 20]. Also PRISMA-7 is a fast and easily implemented 
frailty tool in clinical practice [21] and it has been found to 
have high sensitivity and moderate specificity for identify-
ing frailty among community-dwelling older people [21, 
22]. From five simple instruments to identify frailty in pri-
mary care setting, the PRISMA-7 questionnaire achieved 
the best accuracy and agreement [45]. However, it may 
over-screen for frailty [22]. The FI, instead, consists of 
at least 30 deficits, such as symptoms, signs, disabilities, 
and laboratory measurements, which are readily available 
in survey or clinical data. This approach does not specify 
which deficits, or which combinations of deficits, must 
be present for someone to be considered frail. Also dif-
ferent number of variables can be used [4, 33]. FI is well 
validated and has been applied to multiple datasets [17]. 
According to a systematic review [21], specificity of FI 
was generally high, but sensitivity was low, meaning that 
it may not identify people who might actually be frail and 
thereby could miss potentially critical opportunities for 
treating or supporting these people. In clinical practice, 
it can be time consuming to calculate FI score [40, 46]. 
However, implementation of an electronic FI (eFI) that is 
automatically populated from routine collected data con-
tained within the electronic patient records could represent 
a major advance in the care of older people with frailty or 
with a risk of frailty [47].
The strengths of our study are a large sample size and a 
long follow-up period enabling broad generalizability to the 
community-dwelling older population. To extend generaliz-
ability, we used three validated, commonly used, unweighted 
frailty indexes [48]. Our analyses also have limitations. We 
used modified versions of both FS and PRISMA-7 indexes. 
This may have had impact on frailty classification and pre-
dictive validity for mortality [17, 49]. In addition, interpre-
tation of our results (direct comparisons between indexes 
used) should be made with caution, because scales are 
designed for different purposes, as described earlier.
Although three frailty indexes captured different groups 
of individuals, both being frail and pre-frail predicted higher 
mortality risk according to all three indexes in Finnish 
community-dwelling older people. Simple and fast frailty 
indexes, FS and PRISMA-7, seem to be comparable with a 
multidimensional time-consuming FI in predicting mortal-
ity among community-dwelling older people. Therefore, we 
suggest that FS and/or PRISMA-7 is used for screening older 
people with frailty of risk of frailty in busy clinical settings. 
FI, instead, could be used for having a more comprehensive 
picture of the whole health of older individuals.
Fig. 1  Age- and sex-adjusted survival curves by FRAIL scale (a) and frailty index (b) and unadjusted survival curves by PRISMA-7 (c). The 
median follow-ups were 14.2 (a), 14.3 (b), and 14.5(c) years
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